'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on: March 20,2024 19

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on:March 20,2024 19

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Updated on: January 22,2024 10

Blood cancer manipulates immune cells in order to survive, study shows

byWellcome Trust Sanger InstituteCredit: Pixabay/CC0 Public DomainThe most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumor ce

Updated on:January 22,2024 10

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

by Will Cushman,University of Wisconsin-MadisonA confocal microscope image of lymphoma cells. It shows mitochondrial localization (red) around cell nuclei (blue). Credit: Lixin Rui, University o

Updated on: March 30,2024 0

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

by Will Cushman,University of Wisconsin-MadisonA confocal microscope image of lymphoma cells. It shows mitochondrial localization (red) around cell nuclei (blue). Credit: Lixin Rui, University o

Updated on:March 30,2024 0

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on: January 02,2024 6

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on:January 02,2024 6

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024 12

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024 12

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on: May 27,2024 6

Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology

by Impact Journals LLCUGDH’s roles in cancer biology. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28514A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical on

Updated on:May 27,2024 6

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on: February 24,2024 11

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on:February 24,2024 11

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on: May 11,2024 4

Wide variation in bowel cancer rates after colonoscopies in England

by British Medical JournalBowel cancer survivor John Barnes. Credit: University of LeedsSubstantial variation exists between colonoscopy providers in rates of bowel cancer up to three years after

Updated on:May 11,2024 4

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on: March 30,2024 0

Researchers develop AI-based tool paving the way for personalized cancer treatments

byArizona State UniversityAnalyzing nearly 6,000 MHC-1 complexes, the research team discovered patterns that can identify these preferences and predict immune responses across a broad range of h

Updated on:March 30,2024 0

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024 0

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024 0

Beating by overheating: A new strategy to combat cancer

byNetherlands Cancer InstituteOne could compare cancer cells subjected to the paradoxial approach in this study to the engine of a racing car: if you crank up the RPM and then turn off the cooli

Updated on: March 30,2024 0

Beating by overheating: A new strategy to combat cancer

byNetherlands Cancer InstituteOne could compare cancer cells subjected to the paradoxial approach in this study to the engine of a racing car: if you crank up the RPM and then turn off the cooli

Updated on:March 30,2024 0

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on: April 09,2024 10

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on:April 09,2024 10